At the news
? NEUTRALIMPACT 3/10 DEFA14A filed Apr 14, 2026 at 07:36 ET
LeMaitre Vascular filed a definitive proxy statement for its 2026 Annual Meeting, where shareholders will vote on the election of two directors, approval of executive compensation, and ratification of the independent auditor. This follows a recent board change where a director stepped down and was replaced, indicating a board reshuffling.
- 2026 Annual Meeting will be held on June 2, 2026
- Proposals include election of two directors, approval of executive compensation, and ratification of the auditor
- Board size reduced from eight to seven members
- Director Bridget Ross will not stand for re-election
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access